Role of Repeat Staging Laparoscopy in Locoregionally Advanced Gastric or Gastroesophageal Cancer after Neoadjuvant Therapy
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Staging laparoscopy (SL) can identify occult, subradiographic metastatic (M1) disease in patients with gastric or gastroesophageal (G/GEJ) cancer who are unlikely to benefit from gastrectomy. The purpose of this study is to determine the yield of repeat SL following neoadjuvant therapy for G/GEJ adenocarcinoma after initial negative pretreatment SL.
Retrospective review of a prospective database identified patients with locoregionally advanced (T3–4Nany or TanyN+) G/GEJ adenocarcinoma who underwent pretreatment SL. The yield of repeat SL following neoadjuvant therapy was determined.
From 1994 to 2010, 276 patients with locoregionally advanced G/GEJ adenocarcinoma were identified, of whom 244 proceeded to operation after neoadjuvant therapy, at a median time of 105 days. One hundred sixty-four patients (67 %) underwent repeat SL, and 80 patients (33 %) proceeded directly to laparotomy. Occult M1 disease was identified in 12 (7.3 %) and 6 (7.5 %) patients, respectively. In the repeat SL cohort, M1 disease was identified at laparoscopy in nine patients (5.5 %). M1 disease not identified by laparoscopy was discovered at laparotomy in three patients (1.8 %). The median follow-up for the study population was 31 months. For patients with M1 disease, median overall survival was 15 months, versus 41 months for patients resected without M1 disease (p < 0.0001).
Occult, subradiographic M1 disease develops in approximately 7 % of patients following neoadjuvant therapy for locoregionally advanced G/GEJ adenocarcinoma. These patients have poor prognosis, and repeat SL can be a valuable tool in selecting patients with locoregionally advanced G/GEJ tumors for potentially curative resection after neoadjuvant therapy.
- Jemal, A, Siegel, R, Xu, J, Ward, E (2010) Cancer statistics, 2010. CA Cancer J Clin. 60: pp. 277-300 CrossRef
- Parkin, DM, Bray, F, Ferlay, J, Pisani, P (2005) Global cancer statistics, 2002. CA Cancer J Clin. 55: pp. 74-108 CrossRef
- Strong, VE (2012) Laparoscopic resection for gastric carcinoma: western experience. Surg Oncol Clin N Am. 21: pp. 141-158 CrossRef
- Siegel, R, Ward, E, Brawley, O, Jemal, A (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 61: pp. 212-236 CrossRef
- Edge, SB, Compton, CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 17: pp. 1471-1474 CrossRef
- Karanicolas PJ, Elkin EB, Jacks LM, et al. Staging laparoscopy in the management of gastric cancer: a population-based analysis. J Am Coll Surg. 2011;213:644–51, 651 e641.
- Asencio, F, Aguilo, J, Salvador, JL (1997) Video-laparoscopic staging of gastric cancer. A prospective multicenter comparison with noninvasive techniques. Surg Endosc. 11: pp. 1153-1158 CrossRef
- Burke, EC, Karpeh, MS, Conlon, KC, Brennan, MF (1997) Laparoscopy in the management of gastric adenocarcinoma. Ann Surg. 225: pp. 262-267 CrossRef
- Sarela, AI, Lefkowitz, R, Brennan, MF, Karpeh, MS (2006) Selection of patients with gastric adenocarcinoma for laparoscopic staging. Am J Surg. 191: pp. 134-138 CrossRef
- Power, DG, Schattner, MA, Gerdes, H (2009) Endoscopic ultrasound can improve the selection for laparoscopy in patients with localized gastric cancer. J Am Coll Surg. 208: pp. 173-178 CrossRef
- Bentrem, D, Wilton, A, Mazumdar, M (2005) The value of peritoneal cytology as a preoperative predictor in patients with gastric carcinoma undergoing a curative resection. Ann Surg Oncol. 12: pp. 347-353 CrossRef
- Bonenkamp, JJ, Songun, I, Hermans, J, Velde, CJ (1996) Prognostic value of positive cytology findings from abdominal washings in patients with gastric cancer. Br J Surg. 83: pp. 672-674 CrossRef
- Burke, EC, Karpeh, MS, Conlon, KC, Brennan, MF (1998) Peritoneal lavage cytology in gastric cancer: an independent predictor of outcome. Ann Surg Oncol. 5: pp. 411-415 CrossRef
- Fukagawa, T, Katai, H, Saka, M (2010) Significance of lavage cytology in advanced gastric cancer patients. World J Surg. 34: pp. 563-568 CrossRef
- Jain, VK, Cunningham, D, Chau, I (2012) Preoperative and postoperative chemotherapy for gastric cancer. Surg Oncol Clin N Am. 21: pp. 99-112 CrossRef
- Cunningham, D, Allum, WH, Stenning, SP (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 355: pp. 11-20 CrossRef
- Macdonald, JS, Smalley, SR, Benedetti, J (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 345: pp. 725-730 CrossRef
- Stahl, M, Walz, MK, Stuschke, M (2009) Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol. 27: pp. 851-856 CrossRef
- Ychou, M, Boige, V, Pignon, JP (2011) Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol. 29: pp. 1715-1721 CrossRef
- Fields, RC, Strong, VE, Gonen, M (2011) Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinoma. Br J Cancer. 104: pp. 1840-1847 CrossRef
- Role of Repeat Staging Laparoscopy in Locoregionally Advanced Gastric or Gastroesophageal Cancer after Neoadjuvant Therapy
Annals of Surgical Oncology
Volume 20, Issue 2 , pp 548-554
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Gastric and Mixed Tumor Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
- 2. Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
- 3. Gastrointestinal Oncology Service, Department of Medicine, Weill Cornell Medical College, New York, NY, USA